Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

Treatment of obstructive sleep apnoea (OSA) in adults is evolving, as new therapies have
been explored and introduced in clinical practice, while other approaches have been refined …

Obstructive sleep apnea (OSA) is a highly prevalent disease, and is traditionally associated
with increased cardiovascular risk. The role of comorbidities in OSA patients has emerged …

Obstructive sleep apnea (OSA) is a complex disorder characterized by collapse of the upper
airway during sleep. Downstream effects involve the cardiovascular, pulmonary, and …

The definition of nocturnal hypertension is night-time BP≥ 120/70 mm Hg (> 110/65 mm Hg
by the new 2017ACC/AHA guidelines; Table 1). Clinic and morning home BP of< 130/80 …

Three recent randomized control trials (RCTs) found that treatment of obstructive sleep
apnea (OSA) with continuous positive airway pressure (CPAP) did not reduce rates of future …

Rationale: Randomized controlled trials showed no effect of positive airway pressure (PAP)
therapy for obstructive sleep apnea (OSA) on cardiovascular (CV) risk. However, patient …

Sleep disorders are highly prevalent in the general population and may be linked in a
bidirectional fashion to stroke, which is one of the leading causes of morbidity and mortality …

Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …